Press release
CT/NG Testing Market Exclusive Report with Detailed Study Analysis
According to the latest research by InsightAce Analytic, the Global CT/NG Testing Market Size is valued at USD 1.8 Bn in 2024 and is predicted to reach USD 4.2 Bn by the year 2034 at a 8.4% CAGR during the forecast period for 2025-2034. Request for
Request For free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1984
Chlamydia trachomatis is a prevalent sexually transmitted bacterium that often presents asymptomatically in women. If left untreated, it can ascend the female reproductive tract, leading to pelvic inflammatory disease (PID), which may result in serious reproductive health complications such as infertility, ectopic pregnancy, and chronic pelvic pain .
Neisseria gonorrhoeae, the causative agent of gonorrhea, is another significant sexually transmitted pathogen, particularly affecting young adults. Populations at elevated risk include individuals with multiple sexual partners, those with concurrent sexually transmitted infections, men who have sex with men (MSM), and sex workers .
List of Prominent Players in the CT/NG Testing Market:
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Hologic, Inc. (US),
• Thermo Fisher Scientific Inc. (US),
• Abbott Laboratories (US),
• Bio-Rad Laboratories, Inc. (US),
• Siemens Healthineers AG (Germany),
• Danaher (US),
• Becton,
• Dickinson and Company (US)
Market Dynamics:
Drivers-
The Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) testing market is experiencing significant growth, propelled by governmental initiatives and financial support aimed at fostering innovation in diagnostic technologies. These incentives enable companies to invest in research and development, infrastructure, and the advancement of sophisticated diagnostic tools. Such support encourages manufacturers to push the boundaries of CT/NG testing, leading to breakthroughs in disease detection, monitoring, and personalized medicine.
Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/1984
Challenges:
Despite the growth prospects, the CT/NG testing market faces challenges related to the high costs of essential reagents, instruments, and vendor setups, which elevate overall expenses. Additional costs include maintenance, insurance, laboratory supervision, and administrative expenses such as rent and office space. These financial burdens may be manageable for large hospitals and reference laboratories with substantial capital budgets but pose significant hurdles for small laboratories, medical offices, and individual practitioners with limited resources.
Regional Trends:
The Asia-Pacific region is anticipated to maintain the highest compound annual growth rate (CAGR) in the CT/NG testing market throughout the forecast period. This growth is attributed to the increasing prevalence of sexually transmitted infections in developing countries, coupled with heightened patient awareness through educational campaigns and expanding governmental efforts. Notably, the Asia-Pacific STD diagnostics market generated revenue of USD 2,177.4 million in 2023 and is projected to reach USD 3,825.9 million by 2030, reflecting a CAGR of 8.4% from 2024
Recent Developments:
• In May 2022, - Abbott said that its Alinity m STI Assay had been approved by the FDA. The test finds and separates four common sexually transmitted diseases (STIs) at the same time. If STIs aren't addressed, they can cause serious health problems, like an increased chance of getting certain cancers or being unable to have children.
• In Oct 2022, Bio-Rad released two Exact Diagnostics molecular controls. The CT/NG Positive Run Control was designed for molecular tests of Chlamydia trachomatis and N. gonorrhoeae. The company said the STI Negative Run Control monitored the absence of Chlamydia trachomatis and Neisseria gonorrhoeae in molecular assays and could be used to detect laboratory testing errors, including contamination events while controlling for sample adequacy.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1984
Segmentation of CT/NG Testing Market-
By Product-
• Assays & kits
• Instruments/Analyzers
By Test Type-
• Laboratory,
• Point-of-care testing
By Technology-
• INAAT,
• PCR,
• Immunodiagnostics
• Others
By End-User-
• Diagnostics & Laboratories
• Hospitals & Clinics
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Get More Information: @
https://www.insightaceanalytic.com/report/ctng-testing-market/1984
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CT/NG Testing Market Exclusive Report with Detailed Study Analysis here
News-ID: 4059290 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Aseptic Fill Finish Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global Aseptic Fill Finish Market Size, Share & Trends Analysis Report By Molecules (Small Molecules & Biologics), Type of Packaging Containers (Ampoules, Cartridges, Syringes, and Vials), Drug Product Types (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines, and Other Products), Target Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases Oncological Disorders, and Other Disorders), Scale…
Biomedical Textiles Market Report on the Untapped Growth Opportunities in the In …
"Biomedical Textiles Market" in terms of revenue was estimated to be worth $15.07 billion in 2023 and is poised to reach $26.85 billion by 2031, growing at a CAGR of 7.69% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request For Free Sample Pages @
https://www.insightaceanalytic.com/request-sample/1480
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Biomedical Textiles market are:
• Growth In Medical Expenditure
• Rapid Growth In…
Bio-LNG Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bio-LNG Market Size, Share & Trends Analysis Report By Application (Automotive, Ships, And Others), Source (Agriculture Residues, Industrial Waste, Household Waste, And Others), Region, Market Outlook And Industry Analysis 2034"
The global Bio-LNG Market is estimated to reach over USD 5133.3 Million by 2034, exhibiting a CAGR of 19.3% during the forecast period.
Request For…
Biocides Market Revenue Report with Forecast to 2034
"Biocides Market" in terms of revenue was estimated to be worth $ 9.50 billion in 2024 and is poised to reach $ 15.25 billion by 2034, growing at a CAGR of 5.0% from 2025 to 2034, according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1637
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Biocides Market are:
• Growing Awareness of Hygiene and Health
• Expansion in…
More Releases for CT/NG
Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equip …
This interesting Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market report has end up being of extraordinary assistance to the modern parts in the market by offering them an overall thought of market dynamic. This Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market report is a wide system of the general market situation that shows the way to the business visionaries whether they will acquire or lose here.…
Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equip …
This study not only includes a detailed analysis of the next market trends from 2021 to 2027, but also a comprehensive assessment of the program's budget and gain, as well as important players. With the support of this comprehensive study, one can readily learn about the consequences of COVID-19 on market progress. This Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market report's most important feature is that it presents…
Inaasahang aabot ng Pilipinas ang Electronic Electronic Industry Industry na uma …
• Ang kumpetisyon sa parehong produkto at pag-install ng elektronikong merkado ng seguridad ay inaasahan na maging mabangis sa hinaharap dahil sa mga bagong nagpasok sa mga supplier ng produkto at din ang pagtaas sa bilang ng mga integrator ng system
• Ang mga pagsulong sa teknolohikal sa industriya ay inaasahang magdadala ng paglago sa hinihingi ng mga elektronikong sistema ng seguridad sa bansa. Ang mga bagong teknolohiya tulad ng Wireless…
Chlamydia Trachomatis And Neisseria Gonorrhoeae (CT/NG) Molecular Diagnostics Ma …
The global Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) molecular diagnostics market was valued at $ 118.7 Million in 2017 and is forecast to grow at a modest 19.05 % CAGR between 2018 and 2025, culminating in 2025 global sales of $ 402.2 Million.
Causal organism for infectious diseases could be bacteria, viruses, parasites or fungi and can be spread, directly or indirectly, from one person to another. Molecular diagnostic is…
Cabinet NG Enhances User Experience with CNG-WebSync
Syncing CNG-SAFE with Third Party Web-Based Apps
HUNTSVILLE, AL – March 20, 2012 – Cabinet NG (CNG), provider of electronic document management and workflow management software, today announced the release of CNG-WebSync, a desktop application that integrates its CNG-SAFE document management system with third party web applications to synchronize data and manage documents from a single interface. When using other web-based applications, CNG-WebSync accelerates user productivity by accessing information from documents…
Cabinet NG Announces CNG-SAFE 7.5
Cabinet NG Announces CNG-SAFE 7.5
User Enhanced Document Management and Electronic Workflow Features
HUNTSVILLE, AL – March 5, 2012 – Cabinet NG (CNG), provider of electronic document management and workflow management software, today announced the release of CNG-SAFE 7.5, the latest version of its complete document management and workflow software product. A main component of this latest release includes automated PDF form field population, user customized displays, and enhancements to CNG-Books, CNG’s…
